Isomorphic Labs secures $600M in funding for AI drug design

by Newsroom



Drug design and development company Isomorphic Labs announced it raised $600 million in its first external funding round.

Thrive Capital led the round, with participation from GV (Google Ventures) and existing investor Alphabet.

WHAT IT DOES

Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs and Google DeepMind

The aim of AlphaFold 3…



Source link

Related Posts

aBOUT uS

About Medical Newswire™ aggregates, publishes and distributes news about the medical industry. In association with EmailWire, Medical Newswire™ provides press release distribution services in the medical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us at these messaging apps:

Mobile/WhatsApp: +1832-716-2363
Skype: groupwebmedia
Telegram: @groupwebmedia

rECENT nEWS

Medical Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC